Form 4: Copart Director James Meeks Granted Stock Options

Copart Director James Meeks received a grant of 17,813 stock options with an exercise price of $38.72, vesting monthly over 12 months.

Summary

• James E. Meeks, a Director of Copart, Inc. (CPRT), was granted 17,813 stock options.
• The options have an exercise price of $38.72 per share.
• The grant date for these options was December 5, 2025.
• These options will vest on a monthly basis over the 12 months following the grant date.
• The options expire on December 5, 2032.
• The transaction was made pursuant to the 2007 Equity Incentive Plan and a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. A routine compensation event that aligns director interests with shareholders, but does not indicate any new operational or financial performance.

Positives

• The grant of stock options aligns the director's interests with long-term shareholder value creation.
• The use of a Rule 10b5-1(c) plan indicates a pre-arranged, systematic approach to equity transactions, reducing concerns about insider trading.

Risks

• The value of the stock options is dependent on the future performance of Copart's stock price; if the stock price does not exceed the exercise price, the options may expire worthless.

Future Outlook

The vesting schedule over the next 12 months indicates a continued incentive for the director to contribute to the company's performance.

Management Comments

• Signed by D. Joseph Meister, attorney-in-fact.

Industry Context

Stock option grants are a common form of executive and director compensation across various industries, particularly in growth-oriented companies, to incentivize long-term performance and align interests with shareholders.

Comparison to Industry Standards

• The grant of stock options to a director is a standard practice in corporate governance, comparable to compensation structures at companies like CarMax (KMX) or Ritchie Bros. Auctioneers (RBA), which also utilize equity incentives to retain and motivate key personnel.
• The vesting schedule over 12 months is a typical short-to-medium term incentive structure, often seen in similar roles across the S&P 500.

Corporate Governance

Related Party Transactions

• The grant of stock options to a director is considered a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: Potential dilution if options are exercised, but also potential for increased long-term value creation due to aligned director incentives.
• Employees: No direct impact mentioned, but part of a broader equity incentive framework.

Next Steps

• The stock options will vest monthly over the 12 months following the grant date of December 5, 2025.
• The director may choose to exercise these options at any time between their vesting date and the expiration date of December 5, 2032, assuming the stock price is above the exercise price.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to an existing director under a pre-arranged plan. While it aligns the director's interests with shareholders, it does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard compensation event.

Keywords

Copart, CPRT, Stock Options, Form 4, Insider Transaction, Director Compensation, Equity Incentive Plan, James Meeks